 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
| «123456789101112» |
- | Prolia (denosumab) / Amgen, Daiichi Sankyo
Phase classification: Denosumab Safety Assessment in Multiple Observational Databases (clinicaltrials.gov) - Feb 8, 2017
P=N/A, N=575462, Active, not recruiting, Sponsor: Amgen
Phase classification: P4 --> P=N/A
- || alendronate / Generic mfg.
New P2/3 trial: Effects of Genistein Aglycone in Glucocorticoid Induced Osteoporosis (clinicaltrials.gov) - Feb 2, 2017
P2/3, N=200, Recruiting, Sponsor: University of Messina
- |||| alendronate / Generic mfg.
Enrollment open: BLADE-PCI Trial (BLADE); PHASE IIB LIPOSOMAL ALENDRONATE STUDY (clinicaltrials.gov) - Feb 1, 2017
P2b, N=270, Recruiting, Sponsor: BIOrest Ltd.
Phase classification: P4 --> P=N/A Not yet recruiting --> Recruiting
- | raloxifene hydrochloride / Generic mfg., alendronate / Generic mfg.
New P4 trial: Osteoporosis Treatment in Post-menopausal Women (clinicaltrials.gov) - Dec 30, 2016
P4, N=500, Not yet recruiting, Sponsor: Taichung Veterans General Hospital
- | Prolia (denosumab) / Amgen, Daiichi Sankyo
New P4 trial: Denosumab Versus Bisphosphonates (Alendronate) in GIOP (clinicaltrials.gov) - Dec 29, 2016
P4, N=220, Not yet recruiting, Sponsor: Tuen Mun Hospital
- alendronate / Generic mfg.
Trial primary completion date: Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide (clinicaltrials.gov) - Dec 19, 2016
P2, N=30, Enrolling by invitation, Sponsor: Northwestern University
Not yet recruiting --> Recruiting Trial primary completion date: Nov 2016 --> Mar 2017
- | Prolia (denosumab) / Amgen, Daiichi Sankyo
Phase classification: Denosumab Safety Assessment in Multiple Observational Databases (clinicaltrials.gov) - Dec 19, 2016
P4, N=575462, Active, not recruiting, Sponsor: Amgen
Trial primary completion date: Nov 2016 --> Mar 2017 Phase classification: P=N/A --> P4
- Prolia (denosumab) / Amgen, Daiichi Sankyo
Trial completion, Enrollment change, Trial primary completion date: Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption (clinicaltrials.gov) - Dec 1, 2016
P4, N=26, Completed, Sponsor: Massachusetts General Hospital
Phase classification: P=N/A --> P4 Recruiting --> Completed | N=40 --> 26 | Trial primary completion date: Dec 2014 --> Apr 2014
- | alendronate / Generic mfg.
Trial suspension, Trial primary completion date: Testosterone and Alendronate in Hypogonadal Men (clinicaltrials.gov) - Dec 1, 2016
P2, N=100, Suspended, Sponsor: Massachusetts General Hospital
Recruiting --> Completed | N=40 --> 26 | Trial primary completion date: Dec 2014 --> Apr 2014 Recruiting --> Suspended | Trial primary completion date: Jun 2016 --> Jun 2017
- | alendronate / Generic mfg.
New P2 trial: ALOSTRA: Alendronate Treatment of Osteoporosis in Rheumatoid Arthritis (clinicaltrials.gov) - Oct 26, 2016
P2, N=160, Recruiting, Sponsor: University of Aarhus
- alendronate / Generic mfg.
Trial primary completion date: 99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis (clinicaltrials.gov) - Oct 19, 2016
P=N/A, N=206, Recruiting, Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Recruiting --> Suspended | Trial primary completion date: Jun 2016 --> Jun 2017 Trial primary completion date: Dec 2016 --> Dec 2017
- | alendronate / Generic mfg.
Trial completion: Alendronate to Prevent Loss of Bronchoprotection in Asthma (clinicaltrials.gov) - Sep 14, 2016
P2/3, N=78, Completed, Sponsor: Milton S. Hershey Medical Center
Trial primary completion date: Dec 2016 --> Dec 2017 Active, not recruiting --> Completed
- alendronate / Generic mfg.
Trial primary completion date: Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis Treatment (clinicaltrials.gov) - Sep 14, 2016
P4, N=120, Recruiting, Sponsor: Mahidol University
Active, not recruiting --> Completed Trial primary completion date: Oct 2016 --> Oct 2017
- alendronate / Generic mfg.
Enrollment closed, Trial primary completion date: Stem Cell Recruitment in Osteoporosis Therapy (clinicaltrials.gov) - Aug 19, 2016
P=N/A, N=46, Active, not recruiting, Sponsor: Johns Hopkins University
Trial primary completion date: Oct 2016 --> Oct 2017 Completed --> Active, not recruiting | Trial primary completion date: Aug 2014 --> Aug 2017
- alendronate / Generic mfg.
Trial completion: Treatment With Alendronate in Patients With Ankylosing Spondylitis (AS) (clinicaltrials.gov) - Aug 10, 2016
P4, N=16, Completed, Sponsor: Göteborg University
Completed --> Active, not recruiting | Trial primary completion date: Aug 2014 --> Aug 2017 Active, not recruiting --> Completed
- alendronate / Generic mfg.
Enrollment open: Pilot Study of Bisphosphonates for Breast Cancer (clinicaltrials.gov) - Aug 9, 2016
P1, N=20, Recruiting, Sponsor: University of Wisconsin, Madison
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- alendronate / Generic mfg.
Trial completion, Enrollment change: EDGE: Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study (clinicaltrials.gov) - Jul 26, 2016
P4, N=27, Completed, Sponsor: University of Alabama at Birmingham
Not yet recruiting --> Recruiting Active, not recruiting --> Completed | N=36 --> 27
- | alendronate / Generic mfg.
Enrollment closed, Trial primary completion date: Alendronate to Prevent Loss of Bronchoprotection in Asthma (clinicaltrials.gov) - Jul 11, 2016
P2/3, N=78, Active, not recruiting, Sponsor: Milton S. Hershey Medical Center
Active, not recruiting --> Completed | N=36 --> 27 Recruiting --> Active, not recruiting | Trial primary completion date: May 2016 --> Aug 2016
- alendronate / Generic mfg.
Enrollment closed, Enrollment change: BOCOMEDEN: Bone Healing After Dental Extraction in Postmenopausal Osteoporotic Women Treated With Alendronate Per os Weekly (clinicaltrials.gov) - Jul 7, 2016
P=N/A, N=66, Active, not recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting --> Active, not recruiting | Trial primary completion date: May 2016 --> Aug 2016 Recruiting --> Active, not recruiting | N=280 --> 66
- alendronate / Generic mfg.
New P4 trial: Effect of Alendronate With β - TCP Bone Substitute in Surgical Therapy of Periodontal Intra-osseous Defects. (clinicaltrials.gov) - Jun 11, 2016
P4, N=32, Completed, Sponsor: Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre
- alendronate / Generic mfg.
New P1 trial: Pilot Study of Bisphosphonates for Breast Cancer (clinicaltrials.gov) - May 24, 2016
P1, N=20, Not yet recruiting, Sponsor: University of Wisconsin, Madison
- alendronate / Generic mfg.
Enrollment open: APART: Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss (clinicaltrials.gov) - May 20, 2016
P4, N=80, Recruiting, Sponsor: University College Dublin
Recruiting --> Active, not recruiting | N=280 --> 66 Not yet recruiting --> Recruiting
- alendronate / Generic mfg.
Trial initiation date: APART: Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss (clinicaltrials.gov) - May 11, 2016
P4, N=80, Not yet recruiting, Sponsor: University College Dublin
Not yet recruiting --> Recruiting Initiation date: Jan 2016 --> May 2016
- alendronate / Generic mfg.
Trial completion: Texture Analysis for Postmenopausal Osteoporosis (clinicaltrials.gov) - Apr 19, 2016
P=N/A, N=36, Completed, Sponsor: University of Chicago
Initiation date: Jan 2016 --> May 2016 Recruiting --> Completed
- || alendronate / Generic mfg.
Trial primary completion date: Testosterone and Alendronate in Hypogonadal Men (clinicaltrials.gov) - Apr 9, 2016
P2, N=100, Recruiting, Sponsor: Massachusetts General Hospital
Recruiting --> Completed Trial primary completion date: Jun 2015 --> Jun 2016
- New trial: Exome Sequencing for Atypical Femoral Fractures (clinicaltrials.gov) - Apr 7, 2016
P=N/A, N=36, Enrolling by invitation, Sponsor: Washington University School of Medicine
- |||| Evenity (romosozumab) / Astellas, Amgen, UCB
Trial completion, P2 data: Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density (clinicaltrials.gov) - Mar 24, 2016
P2, N=419, Completed, Sponsor: Amgen
Trial primary completion date: Jun 2015 --> Jun 2016 Active, not recruiting --> Completed
- alendronate / Generic mfg.
Trial completion, Enrollment change: The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults (clinicaltrials.gov) - Mar 18, 2016
P1, N=28, Completed, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=20 --> 28
- alendronate / Generic mfg.
Trial primary completion date: Cyclic Versus Daily Teriparatide on Bone Mass (clinicaltrials.gov) - Feb 29, 2016
P2, N=140, Active, not recruiting, Sponsor: Helen Hayes Hospital
Active, not recruiting --> Completed | N=20 --> 28 Trial primary completion date: Aug 2015 --> Feb 2016
- |||| Prolia (denosumab) / Amgen, Daiichi Sankyo
Trial completion: Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density (clinicaltrials.gov) - Feb 27, 2016
P2, N=412, Completed, Sponsor: Amgen
Trial primary completion date: Aug 2015 --> Feb 2016 Recruiting --> Completed
- || Prolia (denosumab) / Amgen, Daiichi Sankyo
Enrollment closed: Denosumab Safety Assessment in Multiple Observational Databases (clinicaltrials.gov) - Feb 16, 2016
P=N/A, N=575462, Active, not recruiting, Sponsor: Amgen
Recruiting --> Completed Recruiting --> Active, not recruiting
- |||| alendronate / Generic mfg.
Trial completion, Trial primary completion date: Biorest Liposomal Alendronate With Stenting sTudy (BLAST) (clinicaltrials.gov) - Jan 20, 2016
P2, N=226, Completed, Sponsor: BIOrest Ltd.
Recruiting --> Active, not recruiting Active, not recruiting --> Completed | Trial primary completion date: Aug 2010 --> Dec 2015
- alendronate / Generic mfg.
Enrollment closed: EDGE: Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study (clinicaltrials.gov) - Jan 15, 2016
P4, N=36, Active, not recruiting, Sponsor: University of Alabama at Birmingham
Active, not recruiting --> Completed | Trial primary completion date: Aug 2010 --> Dec 2015 Recruiting --> Active, not recruiting
- |||||| alendronate / Generic mfg.
New P2b trial: BLADE-PCI Trial (BLADE); PHASE IIB LIPOSOMAL ALENDRONATE STUDY (clinicaltrials.gov) - Jan 5, 2016
P2b, N=270, Not yet recruiting, Sponsor: BIOrest Ltd.
- ||| alendronate / Generic mfg., ibandronate sodium hydrate / Generic mfg.
Phase classification, Enrollment change: A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia (clinicaltrials.gov) - Dec 13, 2015
P4, N=1711, Completed, Sponsor: Hoffmann-La Roche
Recruiting --> Active, not recruiting Phase classification: P3 --> P4 | N=2212 --> 1711
- | alendronate / Generic mfg., ibandronate sodium hydrate / Generic mfg.
Phase classification: A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis (clinicaltrials.gov) - Dec 5, 2015
P4, N=341, Completed, Sponsor: Hoffmann-La Roche
Phase classification: P3 --> P4 | N=2212 --> 1711 Phase classification: P3 --> P4
- | alendronate / Generic mfg., ibandronate sodium hydrate / Generic mfg.
Phase classification, Adherence: PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia (clinicaltrials.gov) - Dec 4, 2015
P4, N=545, Completed, Sponsor: Hoffmann-La Roche
Phase classification: P3 --> P4 Phase classification: P3 --> P4
- alendronate / Generic mfg.
Trial initiation date: APART: Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss (clinicaltrials.gov) - Dec 4, 2015
P4, N=80, Not yet recruiting, Sponsor: University College Dublin
Phase classification: P3 --> P4 Initiation date: Feb 2015 --> Jan 2016
- alendronate / Generic mfg., cinacalcet HCl / Generic mfg.
Enrollment open: Renal Osteodystrophy: An Individual Management Approach (clinicaltrials.gov) - Dec 4, 2015
P=N/A, N=120, Recruiting, Sponsor: Hartmut Malluche, MD
Initiation date: Feb 2015 --> Jan 2016 Not yet recruiting --> Recruiting
- || alendronate / Generic mfg.
New P2/3 trial: Platelet Rich Fibrin+1% Alendronate in Treatment of Mandibular Degree II Furcation Defects (clinicaltrials.gov) - Nov 21, 2015
P2/3, N=72, Completed, Sponsor: Government Dental College and Research Institute, Bangalore
- alendronate / Generic mfg.
Enrollment open, Trial primary completion date: 99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis (clinicaltrials.gov) - Nov 19, 2015
P=N/A, N=206, Recruiting, Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting | Trial primary completion date: Aug 2016 --> Dec 2016
- |||||||||| alendronate / Generic mfg., ibandronate sodium hydrate / Generic mfg.
New P3 trial, New P4 trial: A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia (clinicaltrials.gov) - Nov 14, 2015
P3, N=2212, Completed, Sponsor: Hoffmann-La Roche
- |||||||||| alendronate / Generic mfg., ibandronate sodium hydrate / Generic mfg.
New P3 trial, New P4 trial: A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis (clinicaltrials.gov) - Nov 6, 2015
P3, N=338, Completed, Sponsor: Hoffmann-La Roche
- |||||||||| alendronate / Generic mfg., ibandronate sodium hydrate / Generic mfg.
New P3 trial, New P4 trial, Adherence: PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia (clinicaltrials.gov) - Nov 6, 2015
P3, N=515, Completed, Sponsor: Hoffmann-La Roche
- alendronate / Generic mfg.
Trial primary completion date: Treatment With Alendronate in Patients With Ankylosing Spondylitis (AS) (clinicaltrials.gov) - Oct 23, 2015
P4, N=16, Active, not recruiting, Sponsor: Göteborg University
Not yet recruiting --> Recruiting | Trial primary completion date: Aug 2016 --> Dec 2016 Trial primary completion date: Jul 2015 --> Jul 2016
- alendronate / Generic mfg.
Trial primary completion date: Alendronate to Prevent Loss of Bronchoprotection in Asthma (clinicaltrials.gov) - Sep 24, 2015
P2/3, N=76, Recruiting, Sponsor: Milton S. Hershey Medical Center
Trial primary completion date: Jul 2015 --> Jul 2016 Trial primary completion date: Oct 2015 --> May 2016
- alendronate / Generic mfg.
Trial primary completion date: EDGE: Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study (clinicaltrials.gov) - Aug 22, 2015
P4, N=36, Recruiting, Sponsor: University of Alabama at Birmingham
Trial primary completion date: Oct 2015 --> May 2016 Trial primary completion date: Oct 2015 --> May 2016
- alendronate / Generic mfg.
Trial primary completion date: Cyclic Versus Daily Teriparatide on Bone Mass (clinicaltrials.gov) - Aug 20, 2015
P2, N=140, Active, not recruiting, Sponsor: Helen Hayes Hospital
Trial primary completion date: Oct 2015 --> May 2016 Trial primary completion date: Jan 2015 --> Aug 2015
- | alendronate / Generic mfg.
Trial completion, Combination therapy: Parathyroid Hormone (PTH) With Alendronate for Osteoporosis (clinicaltrials.gov) - Aug 17, 2015
P2, N=140, Completed, Sponsor: Helen Hayes Hospital
Trial primary completion date: Jan 2015 --> Aug 2015 No longer recruiting --> Completed
- ||| Prolia (denosumab) / Amgen, Daiichi Sankyo
New trial: Denosumab Safety Assessment in Multiple Observational Databases (clinicaltrials.gov) - Aug 11, 2015
P=N/A, N=575462, Recruiting, Sponsor: Amgen